You Ji-An, Gong Yuhan, Wu Yongzhe, Jin Libo, Chi Qingjia, Sun Da
College of Technology, Hubei Engineering University, Xiaogan, China.
Department of Geotechnical Engineering, Wuhan University of Technology, Wuhan, China.
Front Genet. 2022 Mar 18;12:730920. doi: 10.3389/fgene.2021.730920. eCollection 2021.
RAC1 is involved in the progression of HCC as a regulator, but its prognostic performance and the imbalance of immune cell infiltration mediated by it are still unclear. We aim to explore the prognostic and immune properties of RAC1 in HCC. We separately downloaded the data related to HCC from the Cancer Genome Atlas (TCGA) and GEO database. CIBERSORT deconvolution algorithm, weighted gene co-expression network analysis (WGCNA) and LASSO algorithm participate in identifying IRGs and the construction of prognostic signatures. The study discovered that RAC1 expression was linked to the severity of HCC lesions, and that its high expression was linked to a poor prognosis. Cox analysis confirmed that RAC1 is a clinically independent prognostic marker. M0, M1 and M2 macrophages' abundance are significantly different in HCC. We found 828 IRGs related to macrophage infiltration, and established a novel 11-gene signature with excellent prognostic performance. RAC1-based risk score and M0 macrophage has a good ability to predict overall survival. The immune state of irregular macrophage infiltration may be one of the precursors to carcinogenesis. The RAC1 correlated with M0 macrophage and the risk score to show a good performance to predict the survival of HCC patients.
RAC1作为一种调节因子参与肝癌的进展,但其预后价值以及由其介导的免疫细胞浸润失衡仍不清楚。我们旨在探究RAC1在肝癌中的预后及免疫特性。我们分别从癌症基因组图谱(TCGA)和基因表达综合数据库(GEO)下载了与肝癌相关的数据。CIBERSORT反卷积算法、加权基因共表达网络分析(WGCNA)和套索算法参与识别免疫相关基因(IRGs)并构建预后特征。该研究发现,RAC1表达与肝癌病变的严重程度相关,其高表达与预后不良相关。Cox分析证实,RAC1是一种临床独立预后标志物。肝癌中M0、M1和M2巨噬细胞的丰度存在显著差异。我们发现了828个与巨噬细胞浸润相关的IRGs,并建立了一个具有优异预后性能的新型11基因特征。基于RAC1的风险评分和M0巨噬细胞具有良好的预测总生存期的能力。不规则巨噬细胞浸润的免疫状态可能是致癌作用的前体之一。RAC1与M0巨噬细胞及风险评分相关,对预测肝癌患者的生存情况表现良好。